Results 151 to 160 of about 15,884 (195)

Panduratin A from Boesenbergia rotunda suppresses hepatitis B virus by targeting HNF1α and synergizing with antiviral agents. [PDF]

Chin Med
Thongsri P, Pewkliang Y, Borwornpinyo S, Wongkajornsilp A, Ruenraroengsak P, Anurathapan U, Sobhonslidsuk A, Hongeng S, Sa-Ngiamsuntorn K.   +8 more
europepmc   +1 more source

Use of dual ART in individuals with different HBV serological patterns. [PDF]

Curr Opin HIV AIDS
Swaine T, Bhagani S.
europepmc   +1 more source

Anti-hepatitis B virus effects of traditional Chinese medicine: Learning from clinical trials in the past twenty years. [PDF]

World J Hepatol
Feng X, Li NN, Liu GJ, An C, Liu C.
europepmc   +1 more source

Long-Term Outcomes of Patients Who Receive a Liver Transplant for Hepatitis B With Limited Use of Hepatitis B Immunoglobulin. [PDF]

Clin Transplant
Roldan GA, Loon E, Lake J, Lim N.
europepmc   +1 more source

A Case of Ruptured Hepatocellular Carcinoma As the Initial Presentation of Undiagnosed Hepatitis B-related Cirrhosis in a Young Adult. [PDF]

Cureus
Al Hariri B, Mostafa A, Alhariri J.
europepmc   +1 more source

Hepatitis B virus reactivation in patients with hematologic malignancies treated with Bruton tyrosine kinase inhibitors. [PDF]

Blood Res
Hur JY, Lee JH, Lee JH, Park HS, Park H, Choi Y, Choi JH, Won YW, Yoon SE, Kim WS, Kim SJ.   +10 more
europepmc   +1 more source

Efficacy and Safety of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide Fumarate in Treating Acute-on-Chronic Liver Failure with Hepatitis B Virus: A Network Meta-analysis. [PDF]

Infect Dis Ther
Liu J, Bi Y, Ma X, Xin Y.
europepmc   +1 more source

Postoperative hepatitis B virus reactivation and its impact on survival in HBV-related hepatocellular carcinoma patients undergoing conversion therapy with interventional therapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors. [PDF]

Front Cell Infect Microbiol
Xu S, Pang Q, Wei M, Liu D, Yuan D, Bai T, Wang X, Tang Z, Wu F.   +8 more
europepmc   +1 more source

A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate. [PDF]

Turk J Gastroenterol
Yamazhan T, Zerdali E, Önlen Y, Tosun S, Günal Ö, Batırel A, Hasanoğlu İ, Turunç T, Balcı U, Kaya SY, Karabay O, Yıldız İE, Altunal LN, Özkaya HD, Kaya S, İnci A, Alkan S, Yıldız DS, Bal T, Aydemir EA, Eser N, Uysal S, Acet O, Tabak F, Güner R.   +24 more
europepmc   +1 more source

Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs. [PDF]

Arch Virol
Sato Y, Doi K, Inoue J, Ninomiya M, Tsuruoka M, Sato K, Onuki M, Sawahashi S, Ouchi K, Watanabe K, Niitsuma H, Masamune A.   +11 more
europepmc   +1 more source